| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/25/2012 | CN101836972B Novel purposes of ferulic acid |
| 01/25/2012 | CN101804158B Paste for traumatic injuries |
| 01/25/2012 | CN101797377B Fibrin sealant and preparation method thereof |
| 01/25/2012 | CN101780083B Calcium folinate and phenyl alanine composition and preparation method thereof |
| 01/25/2012 | CN101732279B Aspirin enteric coated tablet with low content of free salicylic acid and preparation process thereof |
| 01/25/2012 | CN101721410B Solid medicinal composition of clopidogrel hydrogen sulfate |
| 01/25/2012 | CN101704826B Chinese medicinal lilac daphne flower bud diterpene ortho-ester compounds |
| 01/25/2012 | CN101642522B Traditional Chinese medicine composition and preparation method thereof |
| 01/25/2012 | CN101612170B Compound injection of Ginkgo Biloba extract and dipyridamole and preparation technology thereof |
| 01/25/2012 | CN101199655B Chinese medicine agent for treating after medicament abortion uterus bleeding |
| 01/25/2012 | CN101002611B Chinese date powder |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101601 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2520436C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/24/2012 | CA2440293C Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2344317C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 01/19/2012 | WO2012008565A1 Imidazoline derivatives |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011112549A3 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/19/2012 | US20120017288 Anticoagulant Fusion Protein Anchored to Cell Membrane |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016023 Combination of Selected Opioids with Muscarine Antagonists for Treating Urinary Incontinence |
| 01/19/2012 | US20120016020 Solid dispersion of alpha-ketoamide derivatives |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | US20120015898 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/19/2012 | US20120015881 Kallikrein-inhibitor therapies |
| 01/19/2012 | US20120015877 Use of gdf traps to increase red blood cell levels |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015867 Therapeutic peptides and method |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014974 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014939 Methods and compositions for the treatment and diagnosis of haemorrhagic conversion |
| 01/19/2012 | US20120014933 Method for Producing Platelets |
| 01/19/2012 | US20120014906 Organic compounds |
| 01/19/2012 | CA2805724A1 Organic compounds |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP2405925A2 Use of serine protease inhibitors in the treatment of neutropenia |
| 01/18/2012 | EP2405906A2 Method of use of vitamin k as energy enhancer in diverse disease states |
| 01/18/2012 | CN102325795A Antibodies against tissue factor pathway inhibitor |
| 01/18/2012 | CN102325528A Activated blood coagulation factor X (FXa) inhibitor |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102321239A Preparation method of water-soluble toluylene compound prodrugs |
| 01/18/2012 | CN102321129A Stilbene glycoside injection and preparation process thereof |
| 01/18/2012 | CN102321092A Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 01/18/2012 | CN102321025A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
| 01/18/2012 | CN102321023A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 01/18/2012 | CN102320956A Sodium ferulate composition freeze-dried powder injection and preparation method thereof |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319410A Vital energy invigorating and blood nourishing traditional Chinese medicine composition, and preparation method thereof |
| 01/18/2012 | CN102319400A Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof |
| 01/18/2012 | CN102319377A Traditional Chinese medicine composition for treating functional uterine bleeding |
| 01/18/2012 | CN102319338A Chinese medicinal medicament for treating myelodysplastic syndrome (MDS) by mainly using natural indigo and realgar and preparation method of Chinese medicinal preparation |
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319214A Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof |
| 01/18/2012 | CN102319206A Stable aqueous solution of recombinant human interleukin-11, and preparation method thereof |
| 01/18/2012 | CN102319192A Enzyme bathing material for clearing toxins of human body and preparation method thereof |
| 01/18/2012 | CN101926756B Solid preparation of clopidogrel or pharmaceutically acceptable salt thereof |
| 01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
| 01/18/2012 | CN101836998B Application of tyrosol glucoside in preparing anti-hemorrhagic shock drug |
| 01/18/2012 | CN101695523B Lactation qi and blood tonifying medicament and preparation method thereof |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101450075B Hydroxyethyl starch 130/0.4 sodium chloride injection and preparation method and use thereof |
| 01/18/2012 | CN101380110B Nutritive composition with iron replenishing function and preparation method thereof |
| 01/18/2012 | CN101342270B Pure natural medicament for treating mediterranean anemia |
| 01/18/2012 | CN101304969B Benzene derivative or salt thereof |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8097279 Chewable soft capsule |
| 01/17/2012 | CA2484269C Compounds and method for coating surfaces in a haemocompatible manner |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2446390C Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 01/17/2012 | CA2320371C Inotropic and diuretic effects of exendin and glp-1 |
| 01/17/2012 | CA2276442C Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006440A2 Endothelial cell production by programming |
| 01/12/2012 | WO2012006101A2 Blood substitutes and uses thereof |
| 01/12/2012 | WO2012005340A1 Tablet containing ferric citrate |
| 01/12/2012 | WO2012005240A1 Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 01/12/2012 | WO2012004900A1 Thienopyrimidine compounds |
| 01/12/2012 | WO2012004437A1 Novel serine protease inhibitor and use thereof |
| 01/12/2012 | WO2012004416A2 Treatment of a disease associated with retinal degenerative disorder |
| 01/12/2012 | WO2012004245A1 Crystalline form of rivaroxaban dihydrate |
| 01/12/2012 | WO2012003554A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 01/12/2012 | WO2011112838A3 Composition and method for treatment of vascular hyperpermeability |
| 01/12/2012 | US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies |
| 01/12/2012 | US20120010391 Bonding Products of Aminated Polysaccharides |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |